ISOPP CAPhO 2025 Symposium: Risk Stratification and Treatment Considerations in Older or Unfit Patients with Haematological Malignancies

Older and unfit patients with haematological malignancies frequently have complex care needs which can lead to worse outcomes. Frailty, cognitive impairment, polypharmacy, socio-economic issues, and co-morbidities are common, and can lead to increased treatment toxicity, admissions, and higher rates of mortality.
Early identification of these complex care needs is vital to optimally manage this patient population and ensure best treatment outcomes.
Empowering pharmacists with tools to assess risk and deliver personalised treatment is crucial for an ageing population, living longer with blood cancers.

Learning Objectives

• Recognise the holistic needs of older or unfit patients
• Define at least 5 assessment tools available for use in clinical practice
• Recognise the impact of frailty and geriatric assessments on risk and treatment stratification in clinical practice
• Evaluate clinical trial data in context of applicability to real world older and unfit patients